Skip to content

Welcome to Discover Pharma! Today is : November 22, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

EADV 2025

  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Protagonist highlights psoriasis pill success and next-gen IL-17 candidate at EADV 2025

    Protagonist Therapeutics has reported new clinical and preclinical data at [...]

    May 5, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Affibody reports positive Phase 3 results for izokibep in hidradenitis suppurativa

    Affibody has reported positive 16-week data from a global Phase [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Opinion & Events,Pharmaceuticals and therapeutics

    EADV 2025: Almirall showcases real-world evidence and pipeline progress in dermatology

    Almirall, a global biopharmaceutical company focused on medical dermatology, has [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Opinion & Events,Pharmaceuticals and therapeutics

    Almirall study shows psoriasis treatment improves skin and psychological well-being

    Almirall has presented new two-year results from its POSITIVE study [...]

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Grifols reports real-world Alzheimer’s data for plasma exchange treatment
    Categories: Central Nervous System
  • ProMIS licenses brain delivery technology to advance Alzheimer’s pipeline
    Categories: Central Nervous System
  • Dicot Pharma starts Phase 2b trial of erectile dysfunction drug
    Categories: Clinical & Regulatory
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top